– CANADA, Mississauga – Crescita Therapeutics Inc. (TSX: CTX | OTC: CRRTF), a growth-oriented, innovation-driven Canadian commercial dermatology company, today announced the appointment of Deborah Shannon-Trudeau to its Board as an Independent Non-Executive Director, effective November 10, 2021.
About Deborah Shannon-Trudeau
Ms. Shannon-Trudeau has over 30 years’ experience in strategy, business development, commercial and manufacturing operations. Formerly, she was SVP Licensing and International Business at Trudeau Corporation, a privately held company specializing in the design, development, and distribution of its own “Trudeau” branded kitchenware products where she pioneered the development of licensing and strategic partnerships.
Ms. Trudeau is Vice-Chair of the Board and Chair of the Governance Committee of the Royal Canadian Mint. In parallel, she serves on the Board of CORIM – Conseil des relations internationales de Montréal. She is a Director on the Board of Governors at St. Mary’s Hospital and served as VP of the Board of the Community Foundation of Greater Montreal where she continues to be involved in its development.
In 2018, Ms. Trudeau became the second Canadian to serve for a two-year term as Global President and Chair of the Board of the International Women’s Forum, headquartered in Washington D.C., an organization counting more that 7,500 women leaders active in 33 countries with a purpose to advance women’s leadership. A dedicated IWF advocate for many years, she has served as a mentor/sponsor to many young women professionals and continues to serve on the Global Board of IWF as Director Emeritus. A graduate of Queen’s University in Health Sciences, Ms. Shannon-Trudeau is bilingual and was recognized as a Canadian Diversity Champion by Women of Influence and as a Women’s Executive Network Top 100 honoree.
About Crescita Therapeutics Inc.
Crescita is a growth-oriented, innovation-driven Canadian commercial dermatology company with in-house R&D and manufacturing capabilities. The Company offers a portfolio of high-quality, science-based non-prescription skincare products and early to commercial stage prescription products. We also own multiple proprietary transdermal delivery platforms that support the development of patented formulations to facilitate the delivery of active ingredients into or through the skin.
For more information : http://www.crescitatherapeutics.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.